Sign In
Buy ARKG
$33.15
-0.260 (-0.778%)
At Close: Jun 08, 2026
Cathie Wood's ARK Invest Buys Over 1.3 Million Shares of This Health Information Company
08:15am, Wednesday, 18'th Aug 2021
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 1.3 million shares of Sema4 Holdings Corp.
How Are Genomics ETFs Responding to Q2 Earnings?
10:00am, Saturday, 14'th Aug 2021
Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.
Cathie Wood's ARK Invest Buys Over 7 Million Shares of This Biotech-Focused SPAC
08:40am, Tuesday, 10'th Aug 2021
A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp.
Cathie Wood's ARK Invest Doubles Down on Buying This Biotech-Focused SPAC
11:16pm, Thursday, 05'th Aug 2021
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought nearly 2 million shares of Soaring Eagle Acquisition Corp.
Genomics Advancements Could Aid Breast Cancer Prevention
01:07pm, Wednesday, 04'th Aug 2021
One of the primary objectives of genomics is to make strides in areas where traditional healthcare procedures and techniques have failed or aren't generating enough in the way of advancements and impr
Meet the ETF That's Betting Against Cathie Wood
09:41am, Wednesday, 04'th Aug 2021
ARK Invest's family of exchange-traded funds (ETFs) has been a force to be reckoned with in the markets over the past few years, and with Cathie Wood at the helm, why not?
Cathie Wood's ARK Invest Buys Over 850,000 Shares of Pacific Bio
08:35am, Tuesday, 03'rd Aug 2021
A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 850,000 shares of Pacific Biosciences of California Inc.
Q2 Growth 'Nothing Short Of Virtuous': Economist
02:49pm, Thursday, 29'th Jul 2021
The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. But maybe they shouldn't be so pessimistic.
Unpacking the Potential of the Synthetic Biology Space
02:25pm, Wednesday, 21'st Jul 2021
As an actively managed exchange traded fund, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) can more nimbly move into new healthcare frontiers than rival index-based products. Synthetic bio
Tech Bubble 2.0 + Inflation Tsunami: How to Play Them Now
01:53pm, Thursday, 15'th Jul 2021
Morgan Stanley warns investors 15% correction coming as market overvalued like dot-com days.
How Healthcare ETFs Can Get Their Swagger Back
01:18pm, Wednesday, 14'th Jul 2021
With mergers and acquisitions activity yet to heat up, healthcare stocks are lagging the broader market to this point in 2021. The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) hasn't been imm
The ARKG ETF and the Intersection of All Things Tech
05:54pm, Tuesday, 13'th Jul 2021
It's often said that disruptive technologies frequently intersect with each other. For example, cloud computing and the Internet of Things (IoT) are frequently linked to advancements in cybersecurity.
Where Will ARK Genomic Revolution ETF Be in 5 Years?
06:12am, Saturday, 10'th Jul 2021
Cathie Wood's genomics ETF is making big bets on the "Genomic Age."
A Comprehensive Guide to Genomic ETFs
05:17pm, Friday, 09'th Jul 2021
Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.
Forget Cathie Wood's Planned Bitcoin ETF, These Stocks Are Smart Buys Now
05:55am, Thursday, 08'th Jul 2021
All of them rank among Wood's favorite stocks.
